Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation

Significant advancements have been achieved in the area of molecular targeted therapy for lung adenocarcinoma (LUAD). However, the complex molecular patterns and high heterogeneity of LUAD confine the efficacy of these therapies to a specific subset of patients; therefore, it is necessary to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Li, Kang, Yanhai, Chen, Denglin, Shi, Linyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433705/
https://www.ncbi.nlm.nih.gov/pubmed/37539739
http://dx.doi.org/10.3892/mmr.2023.13064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433705/
https://www.ncbi.nlm.nih.gov/pubmed/37539739
http://dx.doi.org/10.3892/mmr.2023.13064

Ejemplares similares